6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      IL-32 induces epithelial-mesenchymal transition by triggering endoplasmic reticulum stress in A549 cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Epithelial-mesenchymal transition (EMT) is a key process in the onset and development of idiopathic pulmonary fibrosis (IPF) with unclear mechanisms. Our previous studies found that bleomycin and tunicamycin could induce ER stress and consequently trigger EMT accompanying with IL-32 overexpression. This study was aimed to investigate the effects of IL-32 on EMT and ER stress to elucidate the pathogenesis of IPF.

          Methods

          Human lung adenocarcinoma A549 cells were treated with recombinant human (rh)IL-32, IL-32 siRNA and EMT inducer tunicamycin, or 4-phenylbutyric acid (4-PBA), respectively. Then the cell morphology was observed and the expression of ER-related markers and EMT-related markers were detected by RT-qPCR or western blotting.

          Results

          Stimulation of A549 cells with rhIL-32 led to a morphological change from a pebble-like shape to an elongated shape in a portion of the cells, accompanied by down regulated expression of the epithelial cell marker E-cadherin and up regulated expression of the mesenchymal cell markers N-cadherin, Vimentin, and Zeb-1. However, these rhIL-32 induced changes were inhibited by the ER stress inhibitor 4-PBA. Suppression of IL-32 expression with siRNA inhibited TM-induced EMT. Further stimulation of the A549 cells with rhIL-32 demonstrated an increase in the expression of GRP78, although this increase was also inhibited by 4-PBA.

          Conclusions

          These results suggest that IL-32 induces EMT in A549 cells by triggering ER stress, and IL-32 may be a novel marker for IPF.

          Supplementary information

          Supplementary information accompanies this paper at 10.1186/s12890-020-01319-z.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

          American Journal of Respiratory and Critical Care Medicine, 183(6), 788-824
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Pathogenesis of idiopathic pulmonary fibrosis.

            Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease associated with aging that is characterized by the histopathological pattern of usual interstitial pneumonia. Although an understanding of the pathogenesis of IPF is incomplete, recent advances delineating specific clinical and pathologic features of IPF have led to better definition of the molecular pathways that are pathologically activated in the disease. In this review we highlight several of these advances, with a focus on genetic predisposition to IPF and how genetic changes, which occur primarily in epithelial cells, lead to activation of profibrotic pathways in epithelial cells. We then discuss the pathologic changes within IPF fibroblasts and the extracellular matrix, and we conclude with a summary of how these profibrotic pathways may be interrelated.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Interleukin-32: a cytokine and inducer of TNFalpha.

              We describe the gene structure, regulation, signal transduction. and functions of a cytokine, interleukin (IL)-32. An IL-18 unresponsive cell was converted to a responsive cell by transfection of the IL-18 receptor beta chain, and IL-18-induced microarray revealed high expression of a cytokine-like gene. Although IL-32 does not share sequence homology with known cytokine families, IL-32 induces various cytokines, human TNFalpha, and IL-8 in THP-1 monocytic cells as well as mouse TNFalpha and MIP-2 in Raw macrophage cells. IL-32 activates typical cytokine signal pathways of nuclear factor-kappa B (NF-kappaB) and p38 mitogen-activated protein kinase. IL-32 mRNA is highly expressed in immune tissue rather than other tissues. Human IL-32 exists as four splice variants, and IL-32 from other species were found as expressed sequence tag clones in the databank. Induced in human peripheral lymphocyte cells after mitogen stimulation, in human epithelial cells by IFNgamma, and in NK cells after exposure to the combination of IL-12 plus IL-18, IL-32 may play a role in inflammatory/autoimmune diseases.
                Bookmark

                Author and article information

                Contributors
                ldslwtg@126.com
                txpdoc@126.com
                Journal
                BMC Pulm Med
                BMC Pulm Med
                BMC Pulmonary Medicine
                BioMed Central (London )
                1471-2466
                23 October 2020
                23 October 2020
                2020
                : 20
                : 278
                Affiliations
                [1 ]GRID grid.258164.c, ISNI 0000 0004 1790 3548, The First Clinical Medical College, Jinan University, ; 601 W. Huangpu Avenue, Guangzhou, 510630 China
                [2 ]GRID grid.413390.c, Department of Respiratory Medicine, , The Third Affiliated Hospital of Zunyi Medical University (The First People’s Hospital of Zunyi), ; Zunyi, 563000 Guizhou China
                [3 ]GRID grid.410570.7, ISNI 0000 0004 1760 6682, Institute of Respiratory Diseases, The Second Affiliated Hospital of Army Medical University (Third Military Medical University), ; Chongqing, 400037 China
                [4 ]GRID grid.417409.f, ISNI 0000 0001 0240 6969, Zunyi Medical University, ; Zunyi, 563000 Guizhou China
                [5 ]GRID grid.413390.c, Scientific Research Center, , The Third Affiliated Hospital of Zunyi Medical University (The First People’s Hospital of Zunyi), ; Zunyi, 563000 Guizhou China
                [6 ]GRID grid.413390.c, Department of Respiratory, , The Third Affiliated Hospital of Zunyi Medical University (The First People’s Hospital of Zunyi), ; No.98 Fenghuang Road, Zunyi, 563002 Guizhou China
                Author information
                https://orcid.org/0000-0002-8889-2909
                https://orcid.org/0000-0002-9300-3846
                Article
                1319
                10.1186/s12890-020-01319-z
                7585222
                33097029
                93935e70-46ae-401b-afc5-c22fa82d7666
                © The Author(s) 2020

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 12 June 2020
                : 18 October 2020
                Funding
                Funded by: Guizhou Provincial Natural Science Foundation Project
                Award ID: [2018]5623
                Award ID: [2020]4Y121
                Award Recipient :
                Funded by: Zunyi Respiratory Medicine Talent Base Project
                Award ID: [2019]69
                Award Recipient :
                Funded by: Research and Experimental Development plan of the first People's Hospital of Zunyi
                Award ID: [2020]1
                Award Recipient :
                Funded by: Research and Experimental Development plan of the first People's Hospital of Zunyi
                Award ID: [2020]15
                Award Recipient :
                Funded by: Chinese Medical Association Foundation Project
                Award ID: 08020610139
                Award Recipient :
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2020

                Respiratory medicine
                idiopathic pulmonary fibrosis,epithelial-mesenchymal transition,endoplasmic reticulum stress,il-32

                Comments

                Comment on this article